An autologous point-of-care cell therapy for adults with ischemic HF with reduced ejection fraction was safe and may be ...

To truly test the BNP/NT-proBNP-guided treatment hypothesis, the next step should be the performance of an adequately powered, large-scale study. Ideally, such a study should focus on the sub ...

The inactive N-terminal fragment of pro-brain natriuretic peptide (NT-proBNP) has been linked to ventricular dysfunction in the general population, and is predictive of cardiac events. Corteville ...

This has previously been speculated, as elevated concentrations of BNP or N-terminal pro brain natriuretic peptide (NT-proBNP) in cardiovascular patients were found to be related to immune reactions ...

Participants underwent BP monitoring, ECG, LVEF assessment, and measurement of cardiac biomarkers (high-sensitivity troponin T and NT-proBNP) at baseline and over the 24-week treatment period.

Over half of the doctors surveyed reported that only one in four heart failure patients receive guideline-directed medical ...